D054795Chemicals & DrugsD27.505.696.399.472.58063880.906947Incretinscatalyst:eCommonsLogineCommons LoginFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonDiabetes Unit2.37160.021201963research area of0.8947530.084001477subject area forMedicineCardiologyGeneral Internal MedicineEndocrinologyBeth Israel Deaconess Medical CenterBrigham and Women's HospitalMassachusetts General HospitalDLB20DeepakBhattDeepak L. Bhatt, M.D.42.33510370000000-71.1061649000000081016Bhatt, DeepakVisiting Professor of MedicineJCF4JoseFlorezJose Carlos Florez, M.D.,Ph.D.42.36125700000000-71.0655270000000011724Florez, JoseProfessor of MedicineCSM3ChristosMantzorosChristos Mantzoros, M.D.42.34022770000000-71.1058540000000061846Mantzoros, ChristosProfessor of Medicinetrue1Professor of MedicineProfessor of Medicine32569016Hamid A, Vaduganathan M, Oshunbade AA, Ayyalasomayajula KK, Kalogeropoulos AP, Lien LF, Shafi T, Hall ME, Butler JJournal of cardiovascular pharmacologyAntihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center. J Cardiovasc Pharmacol. 2020 09; 76(3):313-320.J Cardiovasc Pharmacol2020-09-01T00:00:002020Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center.VA69VanitaArodaVanita Aroda, M.D.194408Aroda, VanitaAssociate Professor of Medicinetrue1Assistant Professor of MedicineAssistant Professor of Medicine34333000Rizzo M, Nauck MA, Mantzoros CSMetabolism: clinical and experimentalIncretin-based therapies in 2021 - Current status and perspectives for the future. Metabolism. 2021 09; 122:154843.Metabolism2021-07-30T00:00:002021Incretin-based therapies in 2021 - Current status and perspectives for the future.34560122Aggarwal R, Vaduganathan M, Chiu N, Bhatt DLProgress in cardiovascular diseasesPotential implications of the FDA approval of semaglutide for overweight and obese adults in the United States. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:97-98.Prog Cardiovasc Dis2021-09-21T00:00:002021Potential implications of the FDA approval of semaglutide for overweight and obese adults in the United States.35723666Dorsey-Trevino EG, Kaur V, Mercader JM, Florez JC, Leong AThe Journal of clinical endocrinology and metabolismAssociation of GLP1R Polymorphisms With the Incretin Response. J Clin Endocrinol Metab. 2022 08 18; 107(9):2580-2588.J Clin Endocrinol Metab2022-08-18T00:00:002022Association of GLP1R Polymorphisms With the Incretin Response.33413348Yamada T, Wakabayashi M, Bhalla A, Chopra N, Miyashita H, Mikami T, Ueyama H, Fujisaki T, Saigusa Y, Yamaji T, Azushima K, Urate S, Suzuki T, Abe E, Wakui H, Tamura KCardiovascular diabetologyCardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis. Cardiovasc Diabetol. 2021 01 07; 20(1):14.Cardiovasc Diabetol2021-01-07T00:00:002021Cardiovascular and renal outcomes with SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and network meta-analysis.true1Professor of MedicineProfessor of Medicinetrue1Visiting Professor of MedicineVisiting Professor of Medicinetrue1Associate Professor of MedicineAssociate Professor of MedicineASL29AaronLeongAaron Si Arn Leong, M.D.122960Leong, AaronAssistant Professor of Medicine2Assistant Professor1Associate Professor0Full Professor